scholarly journals A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer

2016 ◽  
Vol 8 (8) ◽  
pp. E681-E683 ◽  
Author(s):  
Shojiro Minomo ◽  
Akihiro Tokoro ◽  
Tomoki Utsumi ◽  
Masahiro Ishihara ◽  
Masanori Akira ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Spinal Cord ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Squamous Cell Lung Cancer ◽  
Term Survival ◽  
Intramedullary Spinal Cord ◽  
Long Term Survival ◽  
Intramedullary Spinal Cord Metastasis

scholarly journals Intramedullary Spinal Cord Metastasis in a Patient With Squamous Cell Lung Cancer

2016 ◽  
Vol 5 (3) ◽  
pp. 227-228
Author(s):  
Tahir Taha Bekçi ◽  
Ramazan Koylu ◽  
Mustafa Çalık ◽  
Süleyman Baktık ◽  
Saniye Göknil Çalık
Keyword(s):  
Lung Cancer ◽  
Spinal Cord ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Squamous Cell Lung Cancer ◽  
Intramedullary Spinal Cord ◽  
Spinal Cord Metastasis ◽  
Intramedullary Spinal Cord Metastasis

scholarly journals A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Hironori Ashinuma ◽  
Satoko Mizuno ◽  
Yasushi Yoshida ◽  
Masato Shingyoji
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Checkpoint Inhibitor ◽  
Checkpoint Inhibitors ◽  
Squamous Cell Lung Cancer ◽  
Term Survival ◽  
Reticular Pattern ◽  
Long Term Prognosis

The management of grade 1 checkpoint inhibitor pneumonitis (CIP) is to withhold immune checkpoint inhibitors; however, the natural history of this condition is unknown. We herein report the case of a woman with squamous cell lung cancer who was a long-term survivor after CIP. After 4 rounds of treatment with nivolumab, a chest CT revealed a reticular pattern and ground-glass attenuation with shrinkage of the primary nodule. Nivolumab treatment was withheld without the administration of steroids. Although she remained asymptomatic, subsequent images revealed an increasing interstitial shadow until 2 months after the stop of nivolumab treatment. Thereafter, the interstitial shadow began to improve spontaneously without steroid treatment. Moreover, although the patient has not received additional therapy, disease control of lung cancer has been obtained within a follow-up period of more than 3 years. Although the exacerbation of CIP may appear on images for several months, asymptomatic cases can be followed without the administration of steroids. If the tumor had already responded prior to the onset of CIP, a favorable long-term prognosis can be expected.

scholarly journals Long-term survival of robotic lobectomy for non-small cell lung cancer: a literature review

2020 ◽  
Vol 2020 ◽  
Author(s):  
Sara Ricciardi ◽  
Federico Davini ◽  
Carmelina C. Zirafa ◽  
Gaetano Romano ◽  
Franca M. A. Melfi
Keyword(s):  
Lung Cancer ◽  
Literature Review ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Term Survival ◽  
Long Term Survival
Sign in / Sign up

Export Citation Format

Share Document